Author

Elyse C. Page

South Australian Health and Medical Research InstituteORCID 0000-0002-8990-2574Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

David T. O. YeungiD· 2 shared Deborah L. WhiteiD· 2 shared Timothy P. HughesiD· 2 shared Agnes S. M. YongiD· 1 shared Andrew S. MooreiD· 1 shared BeiJun CheniD· 1 shared Caitlin E Schutz· 1 shared Charles T. H. ChuahiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

David T. O. YeungORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 15, 2025

Mitochondrial DNA Mutations Determine Favourable Molecular Responses to Targeted Kinase Inhibitor Therapy and Impair Oxidative Phosphorylation

Ilaria Stefania Pagani, Vaidehi Krishnan, John F. Ouyang…·David M. Ross

This study shows that mitochondrial DNA mutations are linked to better responses to kinase inhibitor therapy and reduced oxidative phosphorylation in CML patients.

DOI 10.1101/2025.07.15.664865

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 6, 2025

The STAMP inhibitor asciminib is a new treatment option for ABL-rearranged ALL revealing a novel role for the 5' fusion partner in determining drug response

Laura N Eadie, Daniel P. McDougal, Elias Lagonik…·Deborah L. White

This study shows asciminib effectively treats NUP214::ABL1 ALL in preclinical models by inhibiting ABL1 kinase and improving survival.

DOI 10.1101/2025.05.06.652078

mouseexperimental assay

𝕏 PostBluesky